
Sware Raises $6M to Accelerate Life Sciences Innovation by Automating FDA-Mandated Software Validation

Sware Selected as Box’s 2025 Life Sciences Partner of the Year
September 10, 2025 9:00 AM EST | Boston
We're thrilled to share exciting news that showcases the impact of our work and the strength of our partnerships. Sware has been named Box’s 2025 Life Sciences Partner of the Year! This recognition reflects our exceptional contributions, customer impact, and commitment to excellence within the Box partner ecosystem.
Through our strategic partnership with Box, we are revolutionizing GxP validation for life sciences organizations by providing access to our industry-leading Res_Q platform. Together, we’re delivering best-in-class solutions that modernize validation while maintaining the highest standards of regulatory compliance.
"As our industry continues to modernize its approach to quality and technology, we have a unique opportunity to lead by example," said Chris Jay Jurkiewicz, Head of Global Growth & Partnerships. "This award not only highlights our technological innovation, but our commitment to building partnerships that create meaningful impact for life sciences companies."
This award reinforces our belief that better compliance is possible through collaboration, innovation, and purpose-built technology and signals growing momentum toward our mission to reduce the burden of validation, eliminate inefficiencies, and accelerate delivery of regulated products to market.
This achievement would not be possible without the dedication, passion, and expertise of our entire team. We thank you for your ongoing contributions as we continue to build the future of compliance technology.
— Ellen Reilly, CEO
Become a trusted partner



Nathan McBride
Senior Vice President, IT
Xilio Therapeutics
Nathan McBride
Senior Vice President, IT
Xilio Therapeutics
Nathan McBride
Senior Vice President, IT
Xilio Therapeutics
Featured Resources
The convergence of AI and Quality Management marks a paradigm shift in how Life Sciences organizations meet their GxP obligations. Examine key challenges—from compliance complexities and validation demands to talent shortages and risk management concerns.
Read the WhitepaperAs the life sciences landscape rapidly evolves, technology adoption demands agile validation methods to maintain GxP compliance. Learn how organizations can shift from project-based validation to a process-driven approach, integrating validation into their Quality Management System.
Read the WhitepaperManual computer software validation processes cost life sciences organizations up to 30% in additional project budget. As companies struggle to keep up with a surge of app and software integrations, they incur validation debt: the mounting cost of stretched resources, blanket testing, and missed GxP requirements.
Download the Ebook